Forward-Looking Analysis
Analysts expect a challenging quarter for Xerox, with a consensus EPS forecast of -$0.273 for 2026Q1. No analyst has provided a revenue or net income estimate, but based on historical trends and operational pressures, Xerox is expected to show continued revenue flatness and underperform in profitability. The stock currently holds a “Sell” consensus rating from three Wall Street analysts, with an average price target of $3.50. However, given its high debt load (8× EBITDA), weak cash flow margins, and flat sales, growth catalysts are limited. Analysts from Citigroup and Zacks have downgraded XRX in the past 90 days, highlighting increased risk exposure and weak operational execution. The stock is projected to fall further in the near term with a high probability of trading within a narrow range.
Historical Performance Review
In Q4 2025, Xerox reported revenue of $2.03 billion, a net loss of $73 million, and an EPS of -$0.60, despite gross profit of $579 million. This performance highlights persistent challenges in profitability and cost management, underscoring the need for strategic and operational improvements.
Additional News
Xerox recently expanded its strategic partnership with RJ Young, allowing the latter to provide technical and sales support for Xerox’s SMB clients in Tennessee, Mississippi, and West Virginia. This partnership is aimed at enhancing customer service and support through local expertise. Despite this, broader challenges remain, including flat sales, high debt, and operational inefficiencies. Xerox’s stock has gained in recent weeks, up 27.56% over two weeks, but technical indicators suggest a potential 31.58% decline over the next three months.
Summary & Outlook
Xerox’s financial health remains fragile, marked by a recent net loss and high volatility. While the long-term buy signal from the moving average offers some optimism, the short-term sell signals and high volatility increase the risk of further declines. With a forecasted EPS of -$0.273 and weak operational execution, XRX presents a bearish outlook for 2026Q1. Investors should remain cautious as the company faces limited growth catalysts and high financial leverage. The expansion of its partnership with RJ Young is a positive, but it does not offset the broader operational and structural risks currently facing the company.